Fig. 1From: Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo studyFlow diagram of the study. ECC elective cardiac catheterization, CIN contrast-induced nephropathy, MAE major adverse eventBack to article page